Conference
Immunogenicity of tisagenlecleucel in relapsed/ refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) and diffuse large B-cell lymphoma (DLBCL) patients.
Authors
Mueller KT; Grupp SA; Maude SL; Levine JE; Pulsipher M; Boyer MW; August KJ; Myers GD; Awasthi R; Waldron EK
Volume
36
Pagination
pp. 3044-3044
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2018
DOI
10.1200/jco.2018.36.15_suppl.3044
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X